Search Results 141-150 of 20715 for ulcerative colitis

1. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis - Mayo Clinic

   The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...

2. Hyperbaric oxygen therapy - Doctors & Departments - Mayo Clinic

   Research. Mayo Clinic researchers are examining the use of hyperbaric oxygen therapy in the treatment of moderate to severe ulcerative colitis flares. Mayo's ...

3. A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis · Overview · Participation ...

4. Ileoanal anastomosis (J-pouch) surgery - Mayo Clinic

   This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

5. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) · More about research at Mayo ...

6. Food Allergies Archives - Mayo Clinic News Network

   ... (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. There are two common types: ulcerative colitis ...

7. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

   A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...

8. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   About this study. The purpose of this study is to assess the effectiveness and safety of BMS-986165 in ulcerative colitis. Participation eligibility.

9. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

   The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis. Participation ...

10. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...